Trial
NCT04668768
HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Fox Chase Cancer Center
Collaborators
—
Condition
Lymphoma
Intervention
Glucarpidase
Why stopped
To be terminated due to slow accrual, patient still in follow up
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-22